Latest Period
Q1 2026
Security Snapshot
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) Institutional Ownership
CUSIP: G52441105
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
101
Shares (Excl. Options)
58,434,462
Price
$19.93
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- KMTS on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 58,434,462
- Total 13F value
- $1,173,262,884
- Portfolio coverage rank
- 0.01%
- Share change
- +1,918,302
- Value change
- +$30,753,131
- Number of holders
- 101
- Shares outstanding
- 58,516,314
- SEC-reported price per share
- $20.71
- Insider filing price
- $20.71
Latest holder snapshot
5 signals
Issuer context
Who this page is about.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK is tracked under CUSIP G52441105.
- 101 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 108 to 101 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,489,190,179 to $1,173,262,884.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 101 institutions filings for Q1 2026.
Security key
G52441105
Latest holder period
Q1 2026
13F holders
101
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
KMTS full holder history
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings
KESTRA MEDICAL TECHNOLOGIES, LTD. company facts
KESTRA MEDICAL TECHNOLOGIES, LTD. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G52441105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
KMTS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. | 43% | -18% | $554,798,330 | -$40,705,389 | 25,172,338 | -6.8% | Bain Charger Holdings, L.P. | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 10% | +34% | $118,981,139 | +$31,879,630 | 5,968,664 | +37% | T. Rowe Price Associates, Inc. | 31 Mar 2026 |
| FMR LLC | 10% | +65% | $96,158,179 | +$38,804,570 | 5,225,988 | +68% | FMR LLC | 30 Sep 2025 |
| Endeavour Medtech Growth II LP | 4.2% | -20% | $53,974,682 | -$4,362,972 | 2,448,942 | -7.5% | Endeavour Medtech Growth II LP | 31 Dec 2025 |
As of 31 Mar 2026, 101 institutional investors reported holding 58,434,462 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS). This represents 100% of the company’s total 58,516,314 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
97%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 43% | 25,172,338 | 0% | 15% | $501,684,696 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 10% | 5,968,664 | +37% | 0.01% | $118,957,000 |
| FMR LLC | 9.8% | 5,721,054 | -2.2% | 0.01% | $114,020,606 |
| ANDERA PARTNERS | 4.6% | 2,695,192 | +6.1% | 30% | $53,715,177 |
| Yu Fan | 3.9% | 2,282,519 | 0% | 47% | $45,490,604 |
| BROWN ADVISORY INC | 2.9% | 1,723,730 | +2.1% | 0.06% | $34,353,944 |
| BlackRock, Inc. | 2.9% | 1,689,247 | +37% | 0% | $33,666,691 |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.5% | 1,445,864 | +14% | 0.48% | $28,814,884 |
| ALLIANCEBERNSTEIN L.P. | 2.3% | 1,320,374 | -7.4% | 0.01% | $35,016,318 |
| FRANKLIN RESOURCES INC | 2.1% | 1,243,205 | +31% | 0.01% | $24,777,072 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1% | 1,212,693 | 0% | 0% | $24,168,971 |
| Omega Fund Management, LLC | 1.7% | 1,022,149 | -26% | 12% | $20,371,430 |
| STATE STREET CORP | 1.1% | 671,112 | +54% | 0% | $13,375,262 |
| Hood River Capital Management LLC | 1.1% | 655,877 | +17% | 0.13% | $13,071,629 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.98% | 573,925 | +37% | 0% | $11,441,387 |
| FEDERATED HERMES, INC. | 0.9% | 525,000 | 0% | 0.02% | $10,463,250 |
| NEXT CENTURY GROWTH INVESTORS LLC | 0.78% | 457,558 | -1.8% | 0.66% | $9,119,130 |
| Driehaus Capital Management LLC | 0.76% | 447,315 | -3.4% | 0.07% | $8,914,988 |
| UBS Group AG | 0.6% | 349,687 | +29% | 0% | $6,969,262 |
| GOLDMAN SACHS GROUP INC | 0.49% | 288,354 | +5.8% | 0% | $5,746,895 |
| SEI INVESTMENTS CO | 0.41% | 237,116 | +23% | 0% | $4,725,722 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.37% | 218,827 | 0% | 0% | $4,361,222 |
| MILLENNIUM MANAGEMENT LLC | 0.34% | 197,491 | -9% | 0% | $3,935,996 |
| NORTHERN TRUST CORP | 0.33% | 191,609 | +45% | 0% | $3,818,768 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.29% | 172,174 | +44% | 0% | $3,431,428 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 58,434,462 | $1,173,262,884 | +$30,753,131 | $19.93 | 101 |
| 2025 Q4 | 56,150,806 | $1,489,190,179 | +$139,802,244 | $26.52 | 108 |
| 2025 Q3 | 48,395,709 | $1,149,884,732 | +$50,205,342 | $23.76 | 79 |
| 2025 Q2 | 47,375,461 | $785,486,291 | +$35,826,645 | $16.58 | 73 |
| 2025 Q1 | 44,838,936 | $1,117,387,025 | +$1,117,073,033 | $24.92 | 63 |